Which patients with localized esophageal adenocarcinoma, if any, would you offer nivolumab after lack of pCR to neoadjuvant FLOT?

Would you offer adjuvant nivolumab in patients with localized esophageal adenocarcinoma after lack of pCR to neoadjuvant FLOT?

• Yes, all patients, following adjuvant FLOT
• Yes, all patients, instead of adjuvant FLOT
• Yes, patients with PD-L1 CPS >=5, following adjuvant FLOT
• Yes, patients with PD-L1 CPS >=5, instead of adjuvant FLOT
• No, no data to support this
• Other